Starboard reportedly takes big stake in Tylenol maker Kenvue
Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night.
Activist investor Starboard Value has taken a sizeable stake in Kenvue, the maker of Tylenol and Listerine, and is seeking changes, according to reports Sunday night.
When Tesla Inc. reports third-quarter earnings on Wednesday, the results, for Wall Street, could be about getting back to basics, after some investors soured on a robotics event this month that was heavily-hyped but seen by some as light on specifics.
“Apparently the probate laws in Florida are different, perhaps superseding the will.”
Have a question about your own retirement savings? Email us at HelpMeRetire@marketwatch.com
“You deserve what’s rightfully yours.”
“I don’t expect equities to do as well over the next decade as they have in the past, but I still think they will outperform other options.”
Vistra’s stock is J.P. Morgan’s top pick among independent power producers, even though its shares have already rocketed more than fourfold over the past 12 months.
Google is getting a new leader for its core business, which includes search, ads and commerce, as the tech giant restructures itself for the AI era.
Shares of Expedia Group Inc. jumped more than 7% in after-hours trading Wednesday after the Financial Times reported Uber Technologies Inc. was considering a bid to buy the online travel company.
Shares of Lucid Group Inc. fall 12% in the extended session Wednesday after the EV maker called for larger-than-expected operational losses and quarterly revenue that would be slightly ahead of forecast.